RENOVORX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
RENOVORX, INC. (RNXT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum of 3.92% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum · last filed 2026-08-13
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2025-03-31 was 4.27%, a 5.96% increase year-over-year.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2024-03-31 was 4.03%, a 14.81% increase year-over-year.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2023-03-31 was 3.51%, a 466.13% increase year-over-year.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2022-03-31 was 0.62%.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2025 was 3.68%, a 4.55% increase from fiscal 2024.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2024 was 3.52%, a 3.53% increase from fiscal 2023.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2023 was 3.40%, a 448.39% increase from fiscal 2022.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2022 was 0.62%, a 0.00% change from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 3.92% 10-Q · filed 2026-08-13 | ||||
| 2025-12-31 | 3.68% 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | 3.68% 10-Q · filed 2025-11-13 | ||||
| 2025-06-30 | 4.11% 10-Q · filed 2026-08-13 | ||||
| 2025-03-31 | 4.27% 10-Q · filed 2026-05-14 | ||||
| 2024-12-31 | 3.52% 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | 3.63% 10-Q · filed 2025-11-13 | ||||
| 2024-06-30 | 4.03% 10-Q · filed 2025-08-14 | ||||
| 2024-03-31 | 4.03% 10-Q · filed 2025-05-15 | ||||
| 2023-12-31 | 3.40% 10-K · filed 2025-04-01 | ||||
| 2023-09-30 | 3.40% 10-Q · filed 2024-11-13 | ||||
| 2023-06-30 | 3.51% 10-Q · filed 2024-08-13 | ||||
| 2023-03-31 | 3.51% 10-Q · filed 2024-05-10 | ||||
| 2022-12-31 | 0.62% 10-K · filed 2024-04-01 | 1.93% 10-K · filed 2023-03-31 | |||
| 2022-09-30 | 1.93% 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | 1.93% 10-Q · filed 2023-08-16 | ||||
| 2022-03-31 | 0.62% 10-Q · filed 2023-05-12 | ||||
| 2021-12-31 | 0.62% 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | 0.62% 10-Q · filed 2022-11-14 | ||||
| 2020-12-31 | 1.29% 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |